Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues

BACKGROUND: HBeAg-negative chronic hepatitis B patients require long-term nucleos(t)ide analogues(NAs) because loss of surface antigen (HBsAg) is unusual. Low quantitative HBsAg (qHBsAg) levels can identify patients with higher probability of seroclearance. The aim of our study was to evaluate qHBsA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Broquetas, Teresa, Garcia-Retortillo, Montserrat, Hernandez, Juan José, Puigvehí, Marc, Cañete, Nuria, Coll, Susana, Cabrero, Beatriz, Giménez, Maria Dolors, Solà, Ricard, Carrión, José A.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5708657/
https://ncbi.nlm.nih.gov/pubmed/29190670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188303
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars